How to buy Biofrontera (BFRA) shares in the UK

Learn how to easily invest in Biofrontera shares.

Biofrontera AG
+ $0.20 ( + 3.78%)

Biofrontera AG (BFRA) is a leading biotechnology business based in Germany. In the week up to 14 September Biofrontera shares plunged 8.72% to a closing position of $5.13. Over the last 12 months, Biofrontera's share price has fallen by 30.30% from $8.91. Biofrontera is listed on the NASDAQ and employs 159 staff. All prices are listed in US Dollars.

How to buy shares in Biofrontera

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: BFRA in this case.
  5. Research Biofrontera shares. The platform should provide the latest information available.
  6. Buy your Biofrontera shares. It's that simple.
The whole process can take as little as 15 minutes.

Biofrontera share price (NASDAQ:BFRA)

Use our graph to track the performance of BFRA stocks over time.

Biofrontera shares at a glance

Information last updated 2021-07-09.
Previous close$6.25
Change %-0.64%
Information last updated 2021-09-18.
52-week range$4.67 - $9.87
50-day moving average$5.7821
200-day moving average$6.0103
Wall St. target price$8.5
Dividend yieldN/A (0.37%)
Earnings per share (TTM)$-0.654
eToro Free Stocks

Invest in Biofrontera shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 100x Biofrontera shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Freetrade logo £0 No minimum £2.04
£454.50 total
Capital at risk
eToro Free Stocks logo £0 $50 £2.26
£454.72 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.17
£453.63 total
Capital at risk
Stake logo £0 £50 £2.55
£455.01 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £16.77
£469.23 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £15.07
£467.53 total
Capital at risk
Fineco logo £0 No minimum £4.52
£456.99 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £15.45
£467.91 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Biofrontera stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Biofrontera price performance over time

Historical closes compared with the last close of $6.21

1 week (2021-09-13) 12.40%
1 month (2021-08-20) 16.73%
3 months (2021-06-18) -4.90%
6 months (2021-03-19) 3.85%
1 year (2020-09-18) -30.30%
2 years (2019-09-17) -55.64%
3 years (2018-09-19) -54.44%

Is Biofrontera under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.


Biofrontera's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.5 million (£0.0 million).

The EBITDA is a measure of a Biofrontera's overall financial performance and is widely used to measure a its profitability.


Revenue TTM $27.3 million
Gross profit TTM $26.8 million
Return on assets TTM -10.51%
Return on equity TTM -124.08%
Profit margin -59.74%
Book value $0.76
Market capitalisation $163.5 million

TTM: trailing 12 months

How to short and sell Biofrontera shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "BFRA.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 520 Biofrontera shares held short by investors – that's known as the "short interest". This figure is 73.9% down from 1,996 last month.

There are a few different ways that this level of interest in shorting Biofrontera shares can be evaluated.

Short interest ratio (SIR)

Biofrontera's "short interest ratio" (SIR) is the quantity of Biofrontera shares currently shorted divided by the average quantity of Biofrontera shares traded daily (recently around 6500). Biofrontera's SIR currently stands at 0.08. In other words for every 100,000 Biofrontera shares traded daily on the market, roughly 80 shares are currently held short.

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Biofrontera.

Find out more about how you can short Biofrontera stock.

Biofrontera share dividends


Dividend yield: 0.37% of stock value


Forward annual dividend yield: 0.37% of stock value

Biofrontera has recently paid out dividends equivalent to 0.37% of its share value annually.

Biofrontera's most recent dividend payout was on 3 March 2021.

Share price volatility

Over the last 12 months, Biofrontera's shares have ranged in value from as little as $4.67 up to $9.87. A popular way to gauge a stock's volatility is its "beta".

BFRA.US volatility(beta: 1.51)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biofrontera's is 1.5074. This would suggest that Biofrontera's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Shares similar to Biofrontera

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site